Astrana Health, Inc. (ASTH) - Form 8-K Summary
Business Context and Reporting Period
Astrana Health, Inc., a Delaware corporation, filed this Current Report on Form 8-K on May 7, 2026. The filing announces the financial results for the three months ended March 31, 2026. The company's common stock trades on The Nasdaq Stock Market LLC under the symbol "ASTH."
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) and supplemental data (Exhibit 99.2). The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced exhibits which are not included in the input text.
Material Changes
The filing text does not provide specific data to compare current period results against prior comparable periods. Material changes in financial condition or operations are detailed in the referenced press release and supplemental data.
Guidance, Outlook, and Management Commentary
Management has scheduled a conference call and webcast for May 7, 2026, at 2:30 p.m. Pacific Time to discuss the financial results. An earnings presentation is available on the company's investor relations website. The filing text does not include specific forward-looking guidance, risk factors, or commentary on unusual items; these are expected to be covered in the conference call and the referenced exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net loss, and cash burn figures.
- Examine Exhibit 99.2 (Supplemental Data) for non-GAAP metrics and operational updates.
- Verify the company's liquidity position and runway based on the cash balance reported in the press release.
- Listen to the conference call recording for management's commentary on future growth strategies and potential risks.
- Confirm if the company has updated its full-year 2026 financial guidance during the earnings call.